app_store_button

google_play_button

DK - Details page - Device banner - 894x1036

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

Lyt når som helst, hvor som helst 

The Guardian

Twice a week, the Guardian brings you the latest science and environment news

Science Weekly

The US supreme court dealt a devastating blow to the 1965 Voting Rights Act when it ruled in Louisiana v Callais in April that states cannot consider race in redistricting. Southern states from Tennessee to Alabama have rushed to erase majority-Black districts, sparking chaos for the midterm elections. Kai Wright talks to Stacey Abrams, a voting rights activist and former Georgia house minority leader, about the fallout from the decision, and why, despite it all, she still believes the way forward lies in engaging more voters to participate in democracy. ‘They have fractured communities and said we’re going to scatter these seeds. Our job is to grow,’ she says. Help support our independent journalism at theguardian.com/sciencepod

Stateside with Kai and Carter: Stacey Abrams on why gutting of the US Voting Rights Act is ‘evil’

Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eyecatching stories from the week, including an update on hantavirus. Also on the agenda is the Pentagon’s release of a tranche of never before seen documents relating to UFOs, and a study looking at the link between taking part in cultural activities and slower biological ageing. Help support our independent journalism at theguardian.com/sciencepod

Hantavirus update, Pentagon’s UFO files, can art slow biological ageing?

Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise in relieving the long term effects of traumatic brain injury. Madeleine Finlay talks to journalist Mattha Busby about podcaster Joe Rogan’s role in the story, what else is behind the President’s interest in psychedelic research, and what the order will change in practice for scientists and researchers. Help support our independent journalism at theguardian.com/sciencepod

Strange trip: why Trump is backing psychedelics

To celebrate Sir David Attenborough’s centenary, Madeleine Finlay catches up with natural history writer Patrick Barkham, who has met the celebrated presenter. They explore how the natural world has changed in the century that Attenborough has been on Earth, and how his programming has reflected his growing commitment to highlighting the devastating impacts of the climate crisis on nature and biodiversity. Help support our independent journalism at theguardian.com/sciencepod

100 years on Earth: celebrating David Attenborough’s birthday

Three people have died after an outbreak of hantavirus onboard a cruise ship travelling from Argentina to Cape Verde. The World Health Organization says a total of seven cases – two confirmed by laboratory testing and five suspected – have been identified on the cruise ship so far. It is also investigating whether rare human-to-human transmission of the virus could be behind the cases. Madeleine Finlay talks to Prof Jonathan Ball from Liverpool School of Tropical Medicine to find out where the virus comes from, how it is transmitted to humans, and what health agencies will be doing to try to contain it. Help support our independent journalism at theguardian.com/sciencepod

Hantavirus explained: how does it spread and who is most at risk?

The transition towards renewable energy received a boost last week when representatives from 57 countries met in Santa Marta, Colombia, for a world-first climate meeting aimed at bringing the fossil fuels era to an end. Madeleine Finlay hears from the Guardian’s global environment editor, Jon Watts, about how the landmark conference came about, who was missing, and whether the optimism can translate into real world action. Help support our independent journalism at theguardian.com/sciencepod

‘Historic breakthrough’: could the fossil fuel era be coming to an end?

Madeleine Finlay sits down with co-host and Guardian science editor Ian Sample to talk through three eye-catching stories from the week, including the news that the number of years people in the UK are spending in good health has declined compared with a decade ago. Also on the agenda is the science, tech and nutrition behind two runners at this weekend’s London marathon breaking the two-hour threshold, and an answer to why some old houses feel particularly spooky. Help support our independent journalism at theguardian.com/sciencepod

Sub-two-hour marathon, spooky houses explained and why is UK health in decline?

Social media is awash with content about food intolerances and the symptoms to look out for. But figuring out whether you actually have one, and what’s triggering it, is surprisingly difficult. One avenue people are gravitating towards is at-home testing. Madeleine Finlay sits down with health and lifestyle journalist Rebecca Seal to unpick the science behind these tests. Rebecca explains how they purport to work, how accurate they actually are, and how we can all investigate what we might be intolerant to, without breaking the bank. Rebecca’s book Irritated: The Allergy Epidemic and What We Can Do About It, is out now.. Help support our independent journalism at theguardian.com/sciencepod

Food intolerances: how do you know if you have one?

Madeleine Finlay sits down with science editor Ian Sample to hear about some of the winners of the Breakthrough Prize, which held its ceremony in LA last weekend. Each prize is worth $3m and they’re awarded in physics, maths and life sciences. Madeleine and Ian hear from molecular biologist Jean Bennett, who shared a life sciences prize for her work developing the world’s first FDA-approved gene augmented therapy for sight loss. She explains how a chance encounter while dissecting a brain in medical school led her on a 25-year journey to develop the treatment.. Help support our independent journalism at theguardian.com/sciencepod

Muons, massive waves and restored sight: the winners at the ‘Oscars of science’

Earlier this month the AI company Anthropic said it had created a model so powerful that, out of a sense of responsibility, it was not going to release it to the public. Anthropic says the model, Mythos Preview, excels at spotting and exploiting vulnerabilities in software, and could pose a severe risk to economies, public safety and national security. But is this the whole story? Some experts have expressed scepticism about the extent of the model’s capabilities. Ian Sample hears from Aisha Down, a reporter covering artificial intelligence for the Guardian, to find what the decision to limit access to Mythos reveals about Anthropic’s strategy, and whether the model might finally spur more regulation of the industry.. Help support our independent journalism at theguardian.com/sciencepod

Food intolerances: how do you know if you have one?

Lyt når som helst, hvor som helst

Other podcasts you might like ...